Regulatory Landscape of Regenerative Dermatology: Current Frameworks and Future
Regenerative dermatology offers significant therapeutic potential. Regulation is governed by the US FDA and varies according to product classification. Clinicians should counsel patients on safety and efficacy data prior to initiating regenerative treatments.  .
Authors
- Rachel Ziebart
- Samantha Guhan (ORCID: https://orcid.org/0000-0002-5095-9733)
- Barbara B. Hernandez-Rovira
- Saranya P. Wyles
- Hema Sundaram
Publication Details
- Journal
- Journal of Drugs in Dermatology
- Published
- 2025-12-01
- DOI
- https://doi.org/10.36849/jdd.9402
- Primary Topic
- Biomedical Ethics and Regulation
- Type
- article
- Field-Weighted Citation Impact
- 0.00